1. Entecavir (Bristol-Myers Squibb);Billich;Curr. Opin. Investig. Drugs,2001
2. Budelier, K., Schorr, J., 1995. Preparation and analysis of DNA. In: Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smih, J.A., Struhl, K. (Eds.), Current Protocols in Molecular Biology. Wiley, USA, pp. 2.9.7–2.9.8.
3. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice;Cavanaugh;J. Virol.,1997
4. Chang, T.T., Hadziannis, S., Cianciara, J., Rizetto, M., Schiff, E., Pastore, G., Klesczewski, K., Denisky, G., Hindes, R., 2002. Sustained Viral Load and ALT Who Failed Lamivudine. AASLD, Boston.
5. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection;Colonno;J. Infect. Dis.,2001